RhyGaze
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $97M
Investors
- 5
About RhyGaze
Founded in 2024 and based in Basel, Switzerland, RhyGaze AG focuses on gene therapy solutions designed to enhance vision. RhyGaze AG develops a gene therapy specifically for restoring vision in patients suffering from blinding retinal diseases through cone optogenetics. The company’s core product involves delivering a novel light-sensor gene to cone cells in the retina, which are crucial for high-acuity vision. The therapy aims to enhance light detection capabilities in these cells, with primary users being individuals affected by retinal conditions. RhyGaze is transitioning its gene therapy to a third-party manufacturer while preparing for human clinical trials, targeting regions with a prevalence of retinal diseases such as Europe and North America. The company’s revenue model includes partnerships with pharmaceutical companies and healthcare providers, focusing on B2B transactions as it prepares to commercialize its gene therapy solutions.
Who invested in RhyGaze
5 investors across 2 rounds
See all investors in RhyGaze
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RhyGaze
Who invested in RhyGaze?
RhyGaze has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RhyGaze raised?
RhyGaze has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did RhyGaze last raise money?
RhyGaze's most recent round on record is a Series A, in Jan 2025.
What does RhyGaze do?
Founded in 2024 and based in Basel, Switzerland, RhyGaze AG focuses on gene therapy solutions designed to enhance vision.
Where is RhyGaze headquartered?
RhyGaze is headquartered in Basel, Switzerland.
Which VCs invest in companies like RhyGaze?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at RhyGaze's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RhyGaze? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.